PD-1, PD-L1 and PD-L2 levels differ between patients
In a recent study, published in BMC Cancer last month, [...]
Effect of treatment delay on outcomes in metastatic kidney cancer
A recent study published in Science Direct followed patients with [...]
Clinical characteristics and genomic alterations associated with outcome in chromophobe RCC
A recent study by researchers in New York, USA, and [...]
Advances in systemic treatments for kidney cancer
In this video interview, Professor Jens Bedke, Professor of Urology [...]
CAR can be used to indicate survival in kidney cancer patients
A recent study with Japanese patients, published in Urologic Oncology [...]
Savolitinib shows promise in first-in-human phase 1 study in solid tumours
Results from a first-in-human phase 1 study of savolitinib in [...]
Overall survival data for kidney cancer patients treated with high dose interleukin-2
A retrospective study recently reported in Journal for Immunotherapy of [...]
Complete response of kidney cancer brain metastases to cabozantinib
A recent case study, reported in Case Reports in Urology, [...]
Immune-related adverse events to nivolumab associated with survival
A real-world study recently reported in Journal for Immunotherapy of [...]
Clinical significance of PD-1 and PD-L1 receptors in kidney cancer
A recent study, published in Cancer Science this month, suggests [...]
